Navigation Links
Blunt: Democrats' Flawed Spending Compromise
Date:11/16/2007

WASHINGTON, Nov. 16 /PRNewswire-USNewswire/ -- House Republican Whip Roy Blunt (Mo.) issued the following statement today on congressional Democrats' alleged "compromise" offer to reduce their spending demands from $22 billion to $11 billion:

"This week Democrats offered to 'compromise' and reduce their demand for increased government spending from $22 billion to $11 billion. Interestingly, this offer did not include anything about which programs would receive more or less money. It was an offer devoid of any substance other than big dollar signs and lots of zeroes.

"This is similar to what we have witnessed on SCHIP, where Democrats have said they would be willing to compromise on policy, but not the $35 billion in spending. In other words, even if they agreed to policies that resulted in spending less money, they wouldn't adjust the spending levels to reflect those policies. It raises the question about whether Democrats care about good policy or just about more government spending.

"I do not support spending the hard-earned money of American families just for the sake of spending it. Yet, that is exactly what the majority is proposing. The people of this nation deserve more respect than that. House republicans will not agree to waste more of the American people's money just to say we 'compromised' with the Democrats."


'/>"/>
SOURCE House Republican Whip Roy Blunt
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Blunt: Time to Stop the Politics on SCHIP, and Start the Negotiations
2. Blunt: House Sustains Presidents Veto, Now Lets Get to Work on Genuine Solution
3. Blunt: New SCHIP Bill Addresses None of the Problems With the Old
4. Democrats Cave on Sex Education - Again
5. Gene Studies of Male-Female Differences Often Flawed
6. Report on patients access to cancer drugs uses flawed methods to reached flawed conclusions
7. New Poll Shows Public Distrusts Flawed Healthcare Approach Favored by Governor and Speaker in AB 8
8. Pharmacists Press Conference Urging Senate Majority Leader Harry Reid to Fix Flawed Medicaid Drug Reimbursement Rule
9. Study finds drug spending caps cause some seniors to quit taking key medicines
10. Medicare Spending Caps Cause Seniors to Stop Meds
11. United States continues to have highest level of health spending
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... York, NY (PRWEB) , ... January 17, 2017 , ... ... grand opening of a new showroom at South Dixie Hwy in Miami, FL. , ... Officer at Gym Source. “The new innovative in-store concept is designed to give clients ...
(Date:1/17/2017)... ... ... For breast cancer clinicians and researchers who were unable to attend the ... review and analysis of its highlights, a novel half-day, complimentary meeting—the 14th Annual Best ... February 4, 2017 in Chicago. Chaired by Kathy S. Albain, MD, FACP, FASCO from ...
(Date:1/17/2017)... ... January 17, 2017 , ... Healthful Balance announces ... company, owned and operated by Ed Stroup, was created to offer the highest ... highest level of customer service. Healthful Balance products can be purchased online through ...
(Date:1/17/2017)... Petersburg, Florida (PRWEB) , ... January 17, 2017 , ... ... the Producers of AsSeenOnTV.pro will be featuring DRTV campaigns regarding the topic of Beauty ... to become a better version of themselves. What better way to commit to these ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... century approach to infusing high speed technology into the fabric of an entire ... the advancement of healthcare and wellness in a yet-to-be-named, health focused campus. Leading ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... Iowa , Jan. 18, 2017   ... that subsidiary Caretta Therapeutics plans, in the second ... Venodol, a topical roll-on intended to provide relief ... opioid and steroidal analgesics. It was developed under ... to commercialize products derived from snake venom. ...
(Date:1/18/2017)...  Dermata Therapeutics, LLC, a biotechnology company developing ... of dermatological diseases, announces dosing the first patient ... 2 acne rosacea study. DMT210 is a topical ... in the skin responsible for the inflammation and ... This clinical trial, DMT210-003, is a 12-week, Phase ...
(Date:1/18/2017)... Jan. 17, 2017  With an annual growth ranging from 6% to 10%, ... SEA (Jakarta International Expo, March 22-24, 2017) serves the industry by fostering the ... CPhI SEA 2017? Investment Forum ASEAN -- ... Richer conference content Enhanced business matchmaking program ... ...
Breaking Medicine Technology: